Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Stress vesicles link epidermal mechanotransduction to stem cell differentiation.
Journal: Nature communications
Published: November 04, 2025
LNS8801: An Enantiomerically Pure Agonist of the G Protein-Coupled Estrogen Receptor Suitable for Clinical Development.
Journal: Cancer research communications
Published: December 17, 2024
LNS8801: An enantiomerically pure agonist of the G protein-coupled estrogen receptor suitable for clinical development.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024
An In Vivo Study of LNS8801, a GPER Agonist, in a Spontaneous Melanoma-Prone Mouse Model, TGS.
Journal: Pigment cell & melanoma research
Published: March 08, 2024
Analysis of human GPER expression in normal tissues and select cancers using immunohistochemistry.
Journal: bioRxiv : the preprint server for biology
Published: March 22, 2023
LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway.
Journal: Cancer research communications
Published: November 23, 2022
Monitoring cell fate in 3D organotypic human squamous epithelial cultures.
Journal: STAR protocols
Published: October 19, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling.
Journal: Science advances
Published: September 02, 2022
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
Journal: Nature communications
Published: August 11, 2022
ZIP9 Is a Druggable Determinant of Sex Differences in Melanoma.
Journal: Cancer research
Published: April 07, 2021
Drug Resistant Melanoma May Be Vulnerable to Inhibitors of Serine Synthesis.
Journal: The Journal of investigative dermatology
Published: May 26, 2020
Last Updated: 09/26/2026